Kingdon Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Kingdon Capital Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-124,866	Closed	-$2.07M	–	152
2017 Q2	$2.07M	Sell	124,866 -325,505	-72%	-$4.53M	0.14%	85
2017 Q1	$6.21M	Buy	450,371 +199,615	+80%	+$3.21M	0.34%	66
2016 Q4	$4.76M	Buy	250,756 +22,109	+10%	+$424K	0.23%	98
2016 Q3	$5.07M	Buy	228,647 +3,367	+1%	+$63.2K	0.23%	84
2016 Q2	$4.12M	Hold	225,280	–	–	0.23%	80
2016 Q1	$4.1M	Sell	225,280 -73,988	-25%	-$1.2M	0.23%	79
2015 Q4	$5.05M	Buy	299,268 +29,268	+11%	+$497K	0.25%	81
2015 Q3	$4.87M	Buy	270,000 +5,000	+2%	+$111K	0.23%	85
2015 Q2	$6.86M	Buy	265,000 +20,000	+8%	+$506K	0.27%	89
2015 Q1	$5.37M	Buy	+245,000	New	+$5.29M	0.23%	107

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kingdon Capital Management's ENTL Position: Q3 2017 in Review

Kingdon Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q3 2017, closing a stake of 124,866 shares — an estimated $2.07M sold.

Kingdon Capital Management first reported a position in ENTL in Q1 2015 and held it in 10 quarters. The position peaked at $6.86M in Q2 2015. 72 funds tracked by Wall St. Rank hold ENTL as of Q3 2017.

Kingdon Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Kingdon Capital Management sold 124,866 Entellus Medical, Inc. Common Stock shares in Q3 2017, an estimated $2.07M.
Kingdon Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
Kingdon Capital Management's Entellus Medical, Inc. Common Stock position peaked at $6.86M in Q2 2015.
72 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q3 2017.

Based on Kingdon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.